These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 19466881)

  • 21. In vitro and in vivo sustained-release characteristics of theophylline matrix tablets and novel cluster tablets.
    Hayashi T; Kanbe H; Okada M; Kawase I; Ikeda Y; Onuki Y; Kaneko T; Sonobe T
    Int J Pharm; 2007 Aug; 341(1-2):105-13. PubMed ID: 17512147
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of ethylcellulose as matrices for controlled release drug delivery.
    Quadir MA; Chanda E; Haider SS; Reza MD; Datta BK
    Pak J Pharm Sci; 2005 Apr; 18(2):29-34. PubMed ID: 16431395
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Once daily, high-dose mesalazine controlled-release tablet for colonic delivery: optimization of formulation variables using Box-Behnken design.
    Elbary AA; Aboelwafa AA; Al Sharabi IM
    AAPS PharmSciTech; 2011 Dec; 12(4):1454-64. PubMed ID: 22038474
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Investigation of the interactions of enteric and hydrophilic polymers to enhance dissolution of griseofulvin following hot melt extrusion processing.
    Bennett RC; Keen JM; Bi YV; Porter S; Dürig T; McGinity JW
    J Pharm Pharmacol; 2015 Jul; 67(7):918-38. PubMed ID: 25645386
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fast and pH-dependent release of domperidone from orally disintegrating tablets.
    Assaf SM; Qandil AM; Al-Ani EA
    Pharm Dev Technol; 2013; 18(4):897-905. PubMed ID: 22304659
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Two- and three-layer tablet drug delivery systems for oral sustained release of soluble and poorly soluble drugs.
    Efentakis M; Naseef H; Vlachou M
    Drug Dev Ind Pharm; 2010 Aug; 36(8):903-16. PubMed ID: 20196641
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Modulation of drug release by utilizing pH-independent matrix system comprising water soluble drug verapamil hydrochloride.
    Baviskar D; Sharma R; Jain D
    Pak J Pharm Sci; 2013 Jan; 26(1):137-44. PubMed ID: 23261739
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anomalous dissolution behaviour of tablets prepared from sugar glass-based solid dispersions.
    van Drooge DJ; Hinrichs WL; Frijlink HW
    J Control Release; 2004 Jul; 97(3):441-52. PubMed ID: 15212876
    [TBL] [Abstract][Full Text] [Related]  

  • 29. pH-independent drug release of an extremely poorly soluble weakly acidic drug from multiparticulate extended release formulations.
    Riis T; Bauer-Brandl A; Wagner T; Kranz H
    Eur J Pharm Biopharm; 2007 Jan; 65(1):78-84. PubMed ID: 16919924
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preparation and in vitro evaluation of sustained release tablet formulations of diclofenac sodium.
    Savaşer A; Ozkan Y; Işimer A
    Farmaco; 2005 Feb; 60(2):171-7. PubMed ID: 15752476
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of hydrophilic natural gums in formulation of oral-controlled release matrix tablets of propranolol hydrochloride.
    Rajesh KS; Venkataraju MP; Gowda DV
    Pak J Pharm Sci; 2009 Apr; 22(2):211-9. PubMed ID: 19339235
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of the molecular size of carboxymethylcellulose and some polymers on the sustained release of theophylline from a hydrophilic matrix.
    Emeje MO; Kunle OO; Ofoefule SI
    Acta Pharm; 2006 Sep; 56(3):325-35. PubMed ID: 19831281
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influence of Carbopol 71G-NF on the release of dextromethorphan hydrobromide from extended-release matrix tablets.
    Fayed MH; Mahrous GM; Ibrahim MA; Sakr A
    Pharm Dev Technol; 2013; 18(5):971-81. PubMed ID: 21639691
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hydroxyethyl Pachyman as a novel excipient for sustained-release matrix tablets.
    Zhou X; Wang P; Wang J; Liu Z; Hong X; Xiao Y; Liu P; Hu X
    Carbohydr Polym; 2016 Dec; 154():1-7. PubMed ID: 27577889
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Formulation and evaluation of time-controlled triple-concentric mefenamic acid tablets for rheumatoid arthritis.
    Patel P; Madan P; Lin S
    Pharm Dev Technol; 2014 May; 19(3):355-62. PubMed ID: 23611159
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Release characteristics and in vitro-in vivo correlation of pulsatile pattern for a pulsatile drug delivery system activated by membrane rupture via osmotic pressure and swelling.
    Lin HL; Lin SY; Lin YK; Ho HO; Lo YW; Sheu MT
    Eur J Pharm Biopharm; 2008 Sep; 70(1):289-301. PubMed ID: 18539015
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A novel three-layered tablet for extended release with various layer formulations and in vitro release profiles.
    Park JS; Shim JY; Park JS; Choi YW; Jeong SH
    Drug Dev Ind Pharm; 2011 Jun; 37(6):664-72. PubMed ID: 21449708
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Concentration influence of some polymers on dermatological hydrogels pH].
    Musiał W; Kubis A
    Polim Med; 2005; 35(3):21-30. PubMed ID: 16440894
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development of push-pull osmotic tablets using chitosan-poly(acrylic acid) interpolymer complex as an osmopolymer.
    Ketjinda W; Sinchaipanid N; Limsuwan P; Leuenberger H; Mitrevej A
    AAPS PharmSciTech; 2011 Mar; 12(1):132-40. PubMed ID: 21181509
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of formulation and process variables on the release of a weakly basic drug from single unit extended release formulations.
    Kranz H; Wagner T
    Eur J Pharm Biopharm; 2006 Jan; 62(1):70-6. PubMed ID: 16154330
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.